Latest filing published 07 Aug 2026 for AMGEN INC, €291k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Derek Miller is a declared insider of Amgen Inc (senior executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 18 March 2022 to 6 August 2026, the count stands at 32 filings.
No open-market purchase appears, only 3 sales worth €1.5M. The rest of the record consists of 27 share grants and 2 option exercises. So far in 2026, the count stands at no purchases and 2 sales.
On 7 August 2026 came the latest disclosure, an option exercise for €291k in Amgen Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 32 declarations